Skip to main content

7 in 7 healthcare insights: from Bell Potter’s Healthcare conference in Sorrento

Bell Direct
March 18, 2025

Our Market Analyst, Grady Wulff, recently had the opportunity of attending Bell Potter’s Healthcare Conference in Sorrento, Melbourne, where they engaged in in-depth discussions with seven executives from some of Australia’s most promising emerging healthcare companies.

View the full interviews below:

  1. From the Helm: QBiotics Group Limited General Counsel, Ebru Davidson
  2. From the helm: Clarity Pharmaceuticals (ASX:CU6), Executive Chairperson, Alan Taylor
  3. From the helm: Orthocell Limited (ASX:OCC), CEO & Managing Director, Paul Anderson
  4. From the helm: Neuren Pharmaceuticals (ASX:NEU), Chief Executive Officer, Jon Pilcher
  5. From the helm: EBR Systems (ASX:EBR), CEO & President, John McCutcheon
  6. From the helm: Imugene (ASX:IMU) CEO & Managing Director, Leslie Chong
  7. From the helm: Immutep (ASX:IMM) CEO & Managing Director, Marc Voigt

Market Update 22 April

Jessica Amir
April 22, 2020

Market Update 21 April

Jessica Amir
April 21, 2020

Market Update 20 April

Jessica Amir
April 20, 2020

Weekly Wrap 17 April

Jessica Amir
April 17, 2020

Market Update 17 April

Jessica Amir
April 17, 2020

Market Update 16 April

Jessica Amir
April 16, 2020

Morning Bell 15 April

Jessica Amir
April 15, 2020

Market Update 9 April

Jessica Amir
April 9, 2020

Weekly Wrap 9 April

Jessica Amir
April 9, 2020

Market Update 8 April

Jessica Amir
April 8, 2020

Morning Bell 7 April

Jessica Amir
April 7, 2020

Morning Bell 6 April

Jessica Amir
April 6, 2020